Short term prediction and aid in diagnosis of preeclampsia
Preeclampsia is a serious multi-system complication of pregnancy, occurring in 3 - 5 % of pregnancies, and it is one of the leading causes of maternal and perinatal morbidity and mortality worldwide.1-3
Preeclampsia is defined as new-onset of hypertension and proteinuria after 20 weeks of gestation. The clinical presentation of preeclampsia and subsequent clinical course of the disease can vary tremendously, making prediction, diagnosis and assessment of disease progression difficult.1-3
Angiogenic factors (sFlt-1 and PlGF) are proven to play an important role in the pathogenesis of preeclampsia and their concentrations in maternal serum are altered even before the onset of the disease making them a tool for prediction and aid in diagnosis of preeclampsia.1-3
In a recent multicentre, prospective study – PROGNOSIS (Prediction of short-term outcome in pregnant women with suspected preeclampsia study) – the Elecsys sFlt-1/PlGF ratio proved to be a helpful tool in enabling clinicians to exclude preeclampsia for 1 week with very high confidence, reassuring women suspected of having the disease that it is safe to go home.4,5
The additional value of first trimester screening combined with the value of the sFlt-1/PlGF ratio as an aid in the diagnosis of PE and short term prediction and the prediction of adverse outcomes provides a complete solution for PE throughout pregnancy
References